Publicaciones en colaboración con investigadoras/es de Centro de Investigación Biomédica en Red de Cáncer (22)

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  2. Metabolism in the tumor cell and beyond

    Molecular Oncology, Vol. 17, Núm. 6, pp. 921-924

  3. SERS analysis of cancer cell-secreted purines reveals a unique paracrine crosstalk in MTAP-deficient tumors

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 52

2022

  1. Implication of Ceramide Kinase/C1P in Cancer Development and Progression

    Cancers, Vol. 14, Núm. 1

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

  3. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

    Journal of Clinical Investigation, Vol. 132, Núm. 7

2021

  1. Identification of androgen receptor metabolic correlome reveals the repression of ceramide kinase by androgens

    Cancers, Vol. 13, Núm. 17

2020

  1. 1H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer

    Journal of Proteome Research, Vol. 19, Núm. 6, pp. 2419-2428

  2. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

    Journal of Clinical Investigation, Vol. 130, Núm. 5, pp. 2435-2450

  3. Oligometastatic prostate adenocarcinoma. Clinical-pathologic study of a histologically under-recognized prostate cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-9

  4. Targeting PML in triple negative breast cancer elicits growth suppression and senescence

    Cell Death and Differentiation, Vol. 27, Núm. 4, pp. 1186-1199

2019

  1. PGC1a suppresses prostate cancer cell invasion through ERRA transcriptional control

    Cancer Research, Vol. 79, Núm. 24, pp. 6153-6165

2018

  1. Cancertool: A visualization and representation interface to exploit cancer datasets

    Cancer Research, Vol. 78, Núm. 21, pp. 6320-6328

  2. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer

    Nature Genetics, Vol. 50, Núm. 2, pp. 219-228

  3. Erratum to: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer (Nature Genetics, (2018), 50, 2, (219-228), 10.1038/s41588-017-0026-3)

    Nature Genetics

  4. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

    Cell Death and Disease, Vol. 9, Núm. 10

  5. Low-dose statin treatment increases prostate cancer aggressiveness

    Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504

  6. MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

    Hepatology, Vol. 67, Núm. 4, pp. 1420-1440

  7. Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism

    Science Advances, Vol. 4, Núm. 1

  8. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409